Hinge Health Income Statement (2023-2026) | HNGE

Income Statement Dec2023 Jun2024 Sep2024 Dec2024 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 89.83M100.61M117.26M139.10M154.21M170.73M182.31M
Cost of Revenue (Quarter) 23.21M44.57M21.17M147.23M63.52M26.70M28.07M
Gross Profit (Quarter) 66.62M79.26M96.09M97.76M126.20M144.03M154.23M
Operating items
Research & Development (Quarter) 24.92M23.79M22.37M279.96M31.92M32.76M30.34M
Selling, General & Administrative (Quarter) 14.35M14.75M17.36M251.24M36.85M24.53M23.02M
Other Operating Expenses (Quarter) -44.08M44.57M35.45M147.23M63.52M59.49M68.80M
Operating Expenses (Quarter) -4.80M83.10M75.18M678.43M132.29M116.77M122.16M
Operating Income (Quarter) -17.55M-3.85M20.91M-580.67M-6.09M27.26M32.07M
EBIT (Quarter) -17.55M-3.85M20.91M-580.67M-6.09M27.26M32.07M
Non-operating items
Non Operating Income (Quarter) 4.99M5.29M5.25M4.69M4.46M4.96M3.87M
Net income details
EBT (Quarter) -12.56M1.45M26.16M-575.98M-1.64M32.22M35.94M
Tax Provisions (Quarter) 0.36M1.10M-0.95M-0.33M0.20M0.12M0.81M
Profit After Tax (Quarter) -12.93M0.34M27.12M-575.65M-1.84M32.09M35.13M
Income from Continuing Operations (Quarter) -12.93M0.35M27.12M-575.65M-1.84M32.09M35.13M
Consolidated Net Income (Quarter) -12.93M0.35M27.12M-575.65M-1.84M32.09M35.13M
Income towards Parent Company (Quarter) -12.93M0.35M27.12M-575.65M-1.84M32.09M35.13M
Preferred Dividend Payments (Quarter) 0.27M1.12M
Net Income towards Common Stockholders (Quarter) -12.93M0.07M27.12M-575.65M-1.84M32.09M34.01M
Additional items
EPS (Basic) (Quarter) -0.960.012.01-13.10-0.022.110.43
EPS (Weighted Average and Diluted) (Quarter) -0.960.012.01-13.10-0.022.110.41
Shares Outstanding (Weighted Average) (Quarter) 13.02M13.46M13.51M13.56M30.19M78.86M54.58M78.62M
Shares Outstanding (Diluted Average) (Quarter) 13.02M16.58M13.56M46.17M54.58M82.39M
EBITDA (Quarter) -17.55M-3.85M20.91M-580.67M-6.09M27.26M34.80M
Tax Rate (Quarter) -2.87%75.86%-3.63%0.06%-12.21%0.38%2.26%